ACTG A randomized treatment-naive individuals to tenofovir-emtricitabine ( TDF/FTC) or abacavir-lamivudine (ABC/3TC) combined with efavirenz (EFV) or. This article reviews some of the differences in initial therapies for HIV infection. ACTG Shows Abacavir/lamivudine and Tenofovir/emtricitabine Provide Similar HIV Suppression at Low Viral Loads.

Author: Shakakree Gojas
Country: Iran
Language: English (Spanish)
Genre: Environment
Published (Last): 1 July 2009
Pages: 392
PDF File Size: 19.71 Mb
ePub File Size: 9.10 Mb
ISBN: 631-9-95173-991-4
Downloads: 90213
Price: Free* [*Free Regsitration Required]
Uploader: Kashakar

Supporting sexual health and relationships for people with learning disabilities 5220 December In relationships, sex and sexual health, people with disabilities often face During the study, kidney health generally improved regardless of the regimen used.

This is due to somewhat involved statistical considerations. All ACTG A subjects with an available week 4 viral load measurement were included in this analysis.

Find out the answers in this section. 55202 Center Support Center. Some limitations of this study should be noted. Prevention of mother-to-child transmission HIV treatment for children and young people Infant feeding Conception Diagnosing children Child developmental issues Support issues for children and young people Reproductive health.

Links between stigma, suicidal thoughts and less HIV testing in Nigerian men who have sex with men 8 hours ago.

Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A

There was no evidence that this association differed by third drug assignment p-value for interaction acgg 0. Open in a separate window. We compared the viral load changes from entry to values obtained at Weeks 1, 2, and 4 between each of the four regimens using Wilcoxon rank sum tests. The information provided atg TheBody should not be used for diagnosing or treating a health problem or a disease. The primary efficacy endpoint was time from randomization to virologic failure.


First-line ART – ACTG A Study

NAM is not responsible for the content of external websites. In summary, we have shown that smaller four-week decline in viral load was associated with a higher rate of subsequent virologic failure. HIV treatment is not a cure, but it is keeping millions of people well. Will Be Any Better? Reference Daar E et al. The Journal of infectious diseases. CollierMD, 5 Margaret A. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: Thus, a comparison of early virologic response between different antiretroviral regimens may provide insights into a regimen’s inherent antiviral activity, although antiretrovirals targeting different steps in the viral replication cycle may result in different decay rates independent of their antiviral activity.

NAM news and opinions Supporting sexual health and relationships for people with learning disabilities 18 December In relationships, sex and sexual health, people with avtg often face The study design therefore included four different major comparisons, one for each permutation of study drugs: Menstrual Changes and HIV. Internal medicine Tokyo, Japan ; 52 7: More News and Info on Clinical Trials. Our study results call into question the value of using early virologic response as a surrogate act expected longer term virologic outcome when comparing the efficacy of different regimens.

Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202

Secondly, the difference between anticipated and actual study outcomes made the actt of equivalence more demanding than originally intended. Is atazanavir-ritonavir equivalent to efavirenz when used in combination with either Kivexa or Truvada? Although no significant difference appeared in any of the paired comparisons between treatment combinations, ACTG was not able to formally demonstrate “equivalence” for any comparison.


We evaluated associations between week 4 VL change 52002 time to virologic failure with Cox proportional-hazards models. This content was checked for accuracy at the time it was written. To conserve sample aliquots for additional analyses, samples were diluted 1: Please review our privacy policy. We found a smaller week 4 virologic response was associated with an increased risk for subsequent virologic failure.

ACTG 5202 — Effectiveness of Different Treatments

Annals of internal medicine. Here are some of the conclusions that the ACTG team arrived at when comparing atazanavir-ritonavir to efavirenz:.

Abacavir in Kivexa was associated with an increased risk of elevated lipids in the blood whether efavirenz or atazanavir-ritonavir was used. The Data Safety Monitoring Board DSMB overseeing the study recommended that the nuke portions of the study be unblinded and participants then had the option of continuing to take their assigned nukes or changing them.

All Rights Reserved TheBody:

Author: admin